Metraipolis › archive › dc_baed9c060bb2
Emerging Therapeutic Synergies: Combining PD-1 Inhibitors With Poly-ADP-Ribose Polymerase (PARP) Inhibitors in the Treatment of Gynecologic Cancers — Europe PMC PMID:41541937
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41541937
- DOI
- 10.7759/cureus.99275
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-07T15:29:44.956Z
- SHA-256 of the archived text
92dc16ff5518583a2344c38ba452fd6a001903f8b876293d87cd56da0800ced0- Stable URL of this page
https://metraipolis.com/documento/dc_baed9c060bb2
How to cite
Emerging Therapeutic Synergies: Combining PD-1 Inhibitors With Poly-ADP-Ribose Polymerase (PARP) Inhibitors in the Treatment of Gynecologic Cancers — Europe PMC PMID:41541937 — Europe PMC (en), https://europepmc.org/article/MED/41541937 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_baed9c060bb2 (Metraipolis archive dc_baed9c060bb2, sha256 92dc16ff5518583a2344c38ba452fd6a001903f8b876293d87cd56da0800ced0)
BibTeX
@misc{dcbaed9c060bb2,
title = {Emerging Therapeutic Synergies: Combining PD-1 Inhibitors With Poly-ADP-Ribose Polymerase (PARP) Inhibitors in the Treatment of Gynecologic Cancers — Europe PMC PMID:41541937},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41541937},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_baed9c060bb2; sha256 92dc16ff5518583a2344c38ba452fd6a001903f8b876293d87cd56da0800ced0},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41541937. Agents can read the archived copy with the MCP tool read_document.